Episcleritis and scleritis: clinical features and treatment results
about
Imaging studies in a case of infectious scleritis after pterygium excisionIs ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital.Evidence-based practice in acute ophthalmology.Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean populationSubconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trialSuppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation.Refractive changes in patients with autoimmune scleritisIgA nephropathy in a patient presenting with scleritis.Clinico-microbiological profile and treatment outcome of infectious scleritis: experience from a tertiary eye care center of IndiaAdverse effects of smoking on patients with ocular inflammation.Identification of multipotent stem/progenitor cells in murine scleraEarly surgical debridement in the management of infectious scleritis after pterygium excision.Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still's disease: a case reportClinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia.Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.Scleritis and peripheral ulcerative keratitis.Bilateral scleritis and sclerokeratitis associated with IgA nephropathy.Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis.Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study.Pharmacotherapy of scleritis: current paradigms and future directions.Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)-report 4: analysis and outcome of scleritis in an East Asian population.Gender and ocular manifestations of connective tissue diseases and systemic vasculitides.Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.Ocular inflammatory diseases associated with rheumatoid arthritis.Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects.Clinical Profile of Patients with Necrotizing Scleritis in a Tertiary Eye Care Center in Southern India.Occult Fungal Scleritis.Uveitis Specialists and Rheumatologists Select Different Therapies for Idiopathic Non-necrotizing Anterior Scleritis.Clinical Spectrum of HLA-B27-associated Ocular Inflammation.Nodular Scleritis Associated with Herpes Zoster Virus: An Infectious and Immune-Mediated Process.Conjunctival Sensation in Scleritis.Bilateral Posterior Scleritis: Analysis of 18 Cases from a Large Cohort of Posterior Scleritis.Experience of scleritis and episcleritis at a tertiary center in Southern Taiwan.Infectious scleritis mimicking severe ocular inflammation: atypical initial presentation.Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis.Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis.Clinical characteristics of scleritis and episcleritis: results from the pacific ocular inflammation study.Deep intramuscular methylprednisolone treatment of recurrent scleritis.
P2860
Q30465494-BF0DA1F8-4D29-4566-8333-7D62F3677373Q30899738-2C68F3B1-2BA1-4C3A-87E4-776DB339BC0DQ33241460-85883C68-DD01-40C2-9553-70FD7791ECFCQ33532262-2A1A08A4-00CB-48BE-B793-72975A1D2563Q34353913-EFAFD1D2-5AD3-4E26-A16A-AB5A1C7FEA5DQ35085846-C4E6B13D-8E8B-4D92-B8C3-FE42C181798DQ35221160-7565C96F-72CB-4D43-B9C6-BEAAA47D44E6Q35571008-C6A693AF-7213-47AC-9C50-D97D914FF5EFQ35574519-41D21D21-9B5C-4452-BD1B-9000F93E927DQ35582413-BE39B7B6-C4DC-4B2C-899C-8A0A8777AE75Q35582576-2DDECD13-4467-423C-823B-C2BD428EB21EQ35684367-C43F62F7-A555-4163-9736-1D48129237A8Q35935963-A2359E31-9F19-4C9F-89A1-5A6F2EF1EA32Q36186069-BCDDD15D-50E0-4C49-B01C-AC0450A20790Q36297036-BC8E2A26-BA56-46AD-B13E-4B939D0D0EB8Q36371451-5781D535-E74D-46FF-B1CE-2F3E759D3771Q36402007-3419311E-338A-4AB2-A4AB-3D293B5FACD4Q36407689-8E97BACF-F68D-4972-A33A-D314D2056043Q36744443-3028368C-9E23-4652-85C1-07D4DA7CD224Q37366062-5B3913E2-2481-46AA-BC40-A2FE3FFF5BF1Q37466204-25B21EE7-3119-48DB-88C8-FC604AC6F7D3Q37643844-7B06DA72-B7C7-47DF-98FE-6D80E9CDEA4DQ37686895-CA02744F-E068-4AC5-A4DB-FEAF2FDDA9D0Q37992705-8D94F350-053B-469B-9BF5-1B909F1568C8Q38169978-97E877A5-E961-4B31-92E1-A2F9E5D3A0FDQ38172584-53DEB0A6-D8CA-4A8E-9E1C-924BBFF4DF5AQ38801020-FA809D98-254E-4606-871A-D35308061245Q38986044-A70ACAD2-69A5-491D-8943-E43805C5E60CQ39169626-3DF8200F-F029-482D-B7AF-65AD158F9AB8Q39287598-F54DD776-1F23-4D1F-99DD-02E52E26ACECQ40610138-E22C4929-BAFE-4742-BD2B-1786DBBBC374Q40702408-668E0177-177C-44FB-9CBB-91452ED673DBQ40878931-8A86C66D-2F70-4780-AE82-C355E52EFD1DQ41213823-39600B49-DFC8-4297-BBBF-39834C5F2D6FQ41986932-1FFE5B84-9469-4EEF-ABAB-F3215B9F0DF6Q42274037-D6014EC7-030D-47FB-AB58-C624145DE032Q43007015-710C543B-6A6D-4578-A7D8-9B9C5201077AQ43601228-FB3A7C85-D292-4304-9534-38A21AFD7BDEQ44690447-18C36701-259E-4939-AFFD-3351CFD5259DQ46417208-1F4E9132-2DAF-45A7-9D04-1DCA770E9F4B
P2860
Episcleritis and scleritis: clinical features and treatment results
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Episcleritis and scleritis: clinical features and treatment results
@ast
Episcleritis and scleritis: clinical features and treatment results
@en
Episcleritis and scleritis: clinical features and treatment results
@nl
type
label
Episcleritis and scleritis: clinical features and treatment results
@ast
Episcleritis and scleritis: clinical features and treatment results
@en
Episcleritis and scleritis: clinical features and treatment results
@nl
prefLabel
Episcleritis and scleritis: clinical features and treatment results
@ast
Episcleritis and scleritis: clinical features and treatment results
@en
Episcleritis and scleritis: clinical features and treatment results
@nl
P2093
P3181
P1476
Episcleritis and scleritis: clinical features and treatment results
@en
P2093
P304
P3181
P356
10.1016/S0002-9394(00)00710-8
P407
P577
2000-10-01T00:00:00Z